Stuart Pyle is a Partner in IBM Consulting’s Life Sciences R&D practice, bringing more than 30 years of experience in digital transformation, R&D operations, and organizational strategy. He helps life sciences organizations navigate AI-driven business transformation by modernizing development pipelines, optimizing operating models, and building the capabilities needed for sustainable innovation.

At IBM, Stuart leads initiatives that integrate advanced technologies into core R&D functions. He advocates for a disciplined, strategic approach to innovation—one that goes beyond running AI pilots to cultivating a culture of continuous learning and measurable improvement. His work frequently focuses on applying metrics such as the Probability of Technical and Regulatory Success (PTRS) to strengthen decision-making and enhance R&D productivity.

A recognized thought leader in the life sciences industry, Stuart regularly shares his insights at leading forums, including the US Pharma and Biotech Summit and Pharma Clinical Innovation USA. His expertise lies in translating emerging technologies into practical solutions that accelerate clinical development, improve operational performance, and ultimately support better patient outcomes.